Incyte (INCY) financial statements
+55391.0%since 2009
- FY2025 revenue
- $5.1B▲ +21.2%
- FY2025 net income
- $1.3B▲ +3,845.0%
- FY2025 diluted EPS
- $6.41▲ +4,173.3%
- FY2025 free cash flow
- $1.4B▲ +443.9%
Incyte income statement
| USD millions | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Period ended | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 |
| Revenue | 5,141 | 4,241 | 3,696 |
| Operating income | 1,515 | 61 | 621 |
| Pretax income | 1,664 | 317 | 834 |
| Net income | 1,287 | 33 | 598 |
| Diluted earnings per share | 6.41 | 0.15 | 2.65 |
Incyte balance sheet
| USD millions | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Period ended | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 |
| Cash and cash equivalents (derived) | 3,098 | 1,689 | 3,215 |
| Total assets | 6,958 | 5,444 | 6,782 |
| Total liabilities | 1,790 | 1,997 | 1,592 |
| Total equity | 5,167 | 3,448 | 5,190 |
Incyte cash flow statement
| USD millions | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Period ended | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 |
| Operating cash flow | 1,413 | 335 | 496 |
| Capital expenditure | -59 | -86 | -32 |
| Free cash flow (derived) | 1,355 | 249 | 464 |
| Share repurchases | 0 | -2,005 | 0 |
Quarterly highlights
| USD millions | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 |
|---|---|---|---|---|
| Period ended | 30 Sep 2026 | 30 Jun 2026 | 31 Mar 2026 | 31 Dec 2025 |
| Revenue (derived) | 1,557 | 1,674 | 1,273 | 1,507 |
| Operating income (derived) | -708 | 698 | 301 | 336 |
| Net income (derived) | -785 | 586 | 303 | 299 |
| Diluted earnings per share | -3.86 | 2.81 | 1.47 | n/a |
| Operating cash flow (derived) | -675 | 508 | 369 | 543 |
| Total assets | 7,287 | 7,873 | 7,339 | 6,958 |
Incyte major shareholders
| Holder | Share of class | Shares | Filed |
|---|---|---|---|
| Felix J. Baker | 15.6% | 31,225,572 | 12 May 2026 |
| Julian C. Baker | 15.6% | 31,223,155 | 12 May 2026 |
| Baker Bros. Advisors (GP) LLC | 15.4% | 30,865,077 | 12 May 2026 |
| Baker Bros. Advisors LP | 15.4% | 30,865,077 | 12 May 2026 |
| BlackRock, Inc. | 7.8% | 15,242,171 | 18 October 2025 |
Incyte 10-K and SEC filings
| Filed | Form | Type | Description |
|---|---|---|---|
| 13 November 2026 | 8-K | Current report | Current report |
| 29 October 2026 | 10-Q | Quarterly report | Quarterly report |
| 29 October 2026 | 8-K | Current report | Current report |
| 31 August 2026 | 8-K | Current report | Current report |
| 28 July 2026 | 10-Q | Quarterly report | Quarterly report |
| 28 July 2026 | 8-K | Current report | Current report |
| 6 July 2026 | 8-K | Current report | Current report |
| 22 June 2026 | 8-K | Current report | Current report |
Common questions
What was Incyte's revenue in fiscal 2025?
Incyte reported $5.1 billion in revenue for fiscal 2025, the year ended 31 December 2025, up 21.2% from fiscal 2024.
What was Incyte's net income in fiscal 2025?
Incyte reported net income of $1.3 billion for fiscal 2025, the year ended 31 December 2025, up 3,845.0% from fiscal 2024. Diluted earnings per share were $6.41.
What was Incyte's free cash flow in fiscal 2025?
Incyte had $1.4 billion in free cash flow in fiscal 2025. Operating cash flow was $1.4 billion and capital expenditure was $58.9 million.
What were Incyte's total assets at the end of fiscal 2025?
Incyte reported total assets of $7.0 billion at the end of fiscal 2025, the year ended 31 December 2025.
How much Incyte history do I get?
Every account gets the full history, annual and quarterly, with first reported values and as of dates.
Start with a free key
Free $10 credits every month, no card.Free $10 credits a month, no card.